3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
9
Breast Neoplasms
8
Colonic Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Respiratory Aspiration
3
Brain Neoplasms
3
Supratentorial Neoplasms
2
Rectal Neoplasms
2
Pituitary Neoplasms
2
Patient Satisfaction
2
Emergence Delirium
2
Agnosia
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Seizures
1
Respiration Disorders
1
Recovery
1
Rare Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Postoperative Cognitive Complications
1
Polyps
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Interventions
Cisplatin
117
Oxaliplatin
111
Fluorouracil
100
Capecitabine
90
Docetaxel
69
Leucovorin
60
Irinotecan
57
Paclitaxel
49
S 1 (combination)
38
pembrolizumab
35
Trastuzumab
31
Radiotherapy
25
Bevacizumab
20
Nivolumab
19
Epirubicin
19
titanium silicide
18
Surgical Procedures, Operative
17
Carboplatin
17
Ramucirumab
16
Cetuximab
15
Gastrectomy
13
apatinib
12
Everolimus
12
Gemcitabine
11
Albumin-Bound Paclitaxel
10
Neoadjuvant Therapy
8
Folfox protocol
8
Drug Therapy
8
Chemotherapy, Adjuvant
8
Radiation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Stomach Neoplasms
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled